Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00873054 · ClinicalTrials.gov registry record

Percutaneous Nephrolithotomy Versus Extracorporeal Shock Wave Lithotripsy

A clinical trial, sponsored by CAMC Health System.

Completed
Registry status
32
Enrollment target

NCT00873054 is a clinical trial that has completed, run by CAMC Health System. The registered enrollment target is 32 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00873054 has completed, sponsored by CAMC Health System.

COMPLETED
Registry status
32 participants
Enrollment target

Study Summary

The investigators main hypothesis is that the stone free rate will be much higher (95%) in patients treated with PCNL than patients treated with ESWL where stone free rate is (60%) to determine which treatment is safe and prevent less stone recurrence.

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2008-10
Est. Completion 2011-01

Sponsor

CAMC Health System

28 total trials

What the Registry Record Tells You About NCT00873054

The ClinicalTrials.gov registry entry for NCT00873054 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CAMC Health System, which has 28 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00873054 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00873054 about?

NCT00873054 is a clinical study titled "Percutaneous Nephrolithotomy Versus Extracorporeal Shock Wave Lithotripsy". The investigators main hypothesis is that the stone free rate will be much higher (95%) in patients treated with PCNL than patients treated with ESWL where stone free rate is (60%) to determine which treatment is safe and prevent less stone recurrence.

What is the current status of trial NCT00873054?

This trial is currently completed. The enrollment target is 32 participants. The study started on 2008-10. Estimated completion is 2011-01.

Who is sponsoring clinical trial NCT00873054?

This trial is sponsored by CAMC Health System, which has 28 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.